Additional Metadata
Persistent URL dx.doi.org/10.3324/haematol.2018.196899, hdl.handle.net/1765/116287
Journal Haematologica
Citation
Hagenbeek, A, Mooij, H., Zijlstra, J, Lugtenburg, P.J, van Imhoff, G, Nijland, M, … Kersten, M.J. (2019). Phase I dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: The HOVON/LLPC Transplant BRaVE study. Haematologica, 104(4), E151–E153. doi:10.3324/haematol.2018.196899